Article
Mitochondrial Aconitase enzymatic activity: a potential long survival biomarker in the blood of ALS patients
2023-01-24
Abstract excerpt
<h4>Background: </h4> Amyotrophic Lateral Sclerosis (ALS) is a multisystemic, progressive, neurodegenerative disorder. Despite it being generally fatal within a period of 2–4 years, it is highly heterogeneous; as a result, survival periods may vary greatly among individual patients. In the absence of a single reliable test for ALS, Biomarkers can serve as tools for diagnosis, prognosis, indicators of therapeutic r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7cc56898-df05-5e2b-a7fc-34a5934e3c85
- DOI
- 10.21203/rs.3.rs-2480485/v1
